KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406)-Reference-Cited by-同舟云学术

KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406)

Published:2010-09 Issue:9 Volume:38 Page:782-791
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Peter Barbara,Hadzijusufovic Emir,Blatt Katharina,Gleixner Karoline V.,Pickl Winfried F.,Thaiwong Tuddow,Yuzbasiyan-Gurkan Vilma,Willmann Michael,Valent Peter

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference54 articles.

1. Diagnosis and treatment of systemic mastocytosis: state of the art;Valent;Br J Haematol,2003

2. Systemic mastocytosis;Akin;Annu Rev Med,2004

3. Mastocytosis: state of the art;Horny;Pathobiology,2007

4. Mast cells and mastocytosis;Metcalfe;Blood,2008

5. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Conference Report of “Year 2000 Working Conference on Mastocytosis.”;Valent;Leuk Res,2001

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The secondary KIT mutation p.Ala510Val in a cutaneous mast cell tumour carrying the activating mutation p.Asn508Ile confers resistance to masitinib in dogs;BMC Veterinary Research;2020-02-19

2. Pharmacological treatment options for mast cell activation disease;Naunyn-Schmiedeberg's Archives of Pharmacology;2016-04-30

3. Combination Therapy for KIT-Mutant Mast Cells: Targeting Constitutive NFAT and KIT Activity;Molecular Cancer Therapeutics;2014-09-24

4. Adult mastocytosis: a review of the Santo António Hospital 's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease;Anais Brasileiros de Dermatologia;2014-01

5. The use of COLD-PCR, DHPLC and GeneScanning for the highly sensitive detection ofc-KITsomatic mutations in canine mast cell tumours;Veterinary and Comparative Oncology;2013-05-08